CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2580
-0.0020 (-0.77%)
Jan 20, 2026, 11:11 AM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $328.21 million as of January 20, 2026. Its market cap has increased by 143.78% in one year.
Market Cap
328.21M
Enterprise Value
350.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 328.21M, an increase of 5,826.96%. That is a compound annual growth rate of 22.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 328.21M | -7.69% |
| Dec 31, 2025 | 355.55M | 164.08% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| Silence Therapeutics | 238.06M |
| OpGen | 183.60M |